283. Acquired pure red cell aplasia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 19 / Drugs : 36 - (DrugBank : 23) / Drug target genes : 20 - Drug target pathways : 102
Acquired pure red cell aplasia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
283 | Acquired pure red cell aplasia | - |
13 | Multiple sclerosis/Neuromyelitis optica | 18.000 |
46 | Malignant rheumatoid arthritis | 16.142 |
51 | Scleroderma | 14.474 |
49 | Systemic lupus erythematosus | 14.472 |
96 | Crohn disease | 14.392 |
284 | Diamond-Blackfan anemia | 14.205 |
60 | Aplastic anemia | 13.393 |
65 | Primary immunodeficiency | 12.917 |
285 | Fanconi anemia | 12.341 |
11 | Myasthenia gravis | 11.857 |
62 | Paroxysmal nocturnal hemoglobinuria | 11.624 |
19 | Lysosomal storage disease | 11.520 |
164 | Oculocutaneous albinism | 10.770 |
45 | Eosinophilic granulomatosis with Polyangiitis | 10.667 |
61 | Autoimmune hemolytic anemia | 9.920 |
42 | Polyarteritis nodosa | 9.846 |
2 | Amyotrophic lateral sclerosis | 9.662 |
66 | IgA nephropathy | 9.371 |
85 | Idiopathic interstitial pneumonia | 8.485 |
162 | Pemphigoid | 8.148 |
228 | Bronchiolitis obliterans | 8.148 |
93 | Primary biliary cholangitis | 8.067 |
286 | Hereditary sideroblastic anemia | 8.000 |
36 | Epidermolysis bullosa | 7.683 |
53 | Sjogren syndrome | 7.578 |
222 | Primary nephrotic syndrome | 7.494 |
28 | Systemic amyloidosis | 7.435 |
40 | Takayasu arteritis | 7.333 |
97 | Ulcerative colitis | 7.051 |
6 | Parkinson disease | 6.973 |
41 | Giant cell arteritis | 6.902 |
56 | Behcet disease | 6.790 |
95 | Autoimmune hepatitis | 6.632 |
55 | Relapsing polychondritis | 6.519 |
234 | Peroxisomal disease (except Adrenoleukodystrophy) | 6.519 |
50 | Dermatomyositis | 6.481 |
20 | Adrenoleukodystrophy | 6.341 |
35 | Pemphigus | 6.341 |
224 | Purpura nephritis | 5.926 |
64 | Thrombotic thrombocytopenic purpura | 5.778 |
326 | Osteopetrosis | 5.778 |
63 | Idiopathic thrombocytopenic purpura | 5.400 |
107 | Juvenile idiopathic arthritis | 5.279 |
302 | Leber hereditary optic neuropathy | 5.000 |
38 | Stevens-Johnson syndrome | 4.719 |
26 | HTLV-1-associated myelopathy | 4.491 |
151 | Rasmussen encephalitis | 4.398 |
39 | Toxic epidermal necrolysis | 4.182 |
226 | Interstitial cystitis with Hunners ulcer | 4.111 |
43 | Microscopic polyangiitis | 3.714 |
274 | Osteogenesis Imperfecta | 3.714 |
331 | Idiopathic multicentric castleman disease | 3.688 |
269 | Pyogenic arthritis | 3.600 |
90 | Retinitis pigmentosa | 3.333 |
113 | Muscular dystrophy | 3.230 |
44 | Wegener granulomatosis | 3.143 |
84 | Sarcoidosis | 3.087 |
299 | Cystic fibrosis | 3.034 |
256 | Muscle glycogenosis | 2.774 |
158 | Tuberous sclerosis | 2.686 |
160 | Congenital ichthyosis | 2.392 |
94 | Primary sclerosing cholangitis | 2.339 |
227 | Osler disease | 2.174 |
16 | Crow-Fukase syndrome | 2.000 |
58 | Hypertrophic cardiomyopathy | 1.765 |
300 | IgG4-related disease | 1.719 |
172 | Hypophosphatasia | 1.407 |
127 | Frontotemporal lobar degeneration | 1.200 |
271 | Ankylosing spondylitis | 1.192 |
34 | Neurofibromatosis | 1.032 |
86 | Pulmonary arterial hypertension | 1.013 |
52 | Mixed connective tissue disease | 1.000 |
220 | Rapidly progressive glomerulonephritis | 1.000 |
30 | Distal myopathy | 1.000 |
137 | Focal cortical dysplasia | 1.000 |
192 | Cockayne syndrome | 1.000 |
277 | Lymphangiomatosis | 1.000 |
281 | Klippel-Trenaunay-Weber syndrome | 1.000 |